Medical Confidentiality. The Employer respects the confidentiality of employee medical records. Under normal circumstances, the Employer also recognizes the entitlement of its employees to their own choice of physician.
Medical Confidentiality. NAMM agrees to comply with applicable federal, state and local laws for handling confidential medical information and shall take all appropriate and reasonable action in developing technological and contractual methods of maintaining confidentiality for any medical or other confidential information converted to electronic data.
Medical Confidentiality. The City respects the confidentiality of employee medical records. Under normal circumstances, the City also recognizes the entitlement of its employees to their own choice of physician.
Medical Confidentiality. The Parties shall adhere to the principles of medical confidentiality in relation to Clinical Trial Subjects. The Medical Records and any other Personal Data of a Clinical Trial Subject shall not be disclosed to the Sponsor or CRO by the Clinical Organisation, save where necessary in any of the following circumstances:
6.2.1 to the extent that the disclosure is required to satisfy the requirements of the Protocol or compliance with applicable laws;
6.2.2 for the purpose of monitoring, auditing or adverse event reporting or investigation;
6.2.3 for the purposes of investigation or defending any claim or proceeding brought by a Clinical Trial Subject in connection with the Clinical Trial; and
6.2.4 for the purpose of allowing the Sponsor to follow-up with the Clinical Trial Subject after the conclusion of the Clinical Trial. The Sponsor and CRO shall not disclose the identity of any Clinical Trial Subject to any third party save in accordance with Data Protection Laws and Guidance or as required by law, and the Clinical Organisation and the relevant Clinical Trial Subject shall be notified by the Sponsor or CRO of such intended disclosure prior to such disclosure being made, unless the Sponsor or CRO is otherwise prohibited from doing so in accordance with applicable law.
Medical Confidentiality. In accordance with the requirements of HIPAA and FERPA, the University shall respect the highly confidential status of all SWs’ medical records maintained by the University, including those that contain information about their transgender status (such as the sex they were assigned at birth).
Medical Confidentiality. The Employer respects the confidentiality of employee medical records. Under normal circumstances, the Employer also recognizes the entitlement of its employees to their own choice of physician. Medical Assessment Where the Employer specifies on reasonable grounds that, it is of the opinion the employee may be medically unfit to work on a regular basis, or may jeopardize the safety of others, the Employer may require the employee to provide at the Employer’sexpense, provided the Health Care Plan does not cover the cost, a Certificate of a licensed physician attesting to his her fitness for work.
Medical Confidentiality. The Parties agree to adhere to the principles of medical confidentiality in relation to Clinical Trial Subjects involved in the Clinical Trial. Personal data (as defined in the Data Protection Act 1998) shall not be disclosed to the Sponsor by the Practice or the Investigator save where this is required to satisfy the requirements of the Protocol or for the purpose of monitoring or adverse event reporting, or in relation to a claim or proceeding brought by the Clinical Trial Subject in connection with the Clinical Trial. The Sponsor shall not disclose the identity of Clinical Trial Subjects to third parties without prior written consent of the Clinical Trial Subject, except in accordance with the provisions of the Data Protection Act 1998 and the principles set out in “Confidentiality: Code of Practice for Health and Social Care in Wales (August 2005)” , unless in relation to a claim or proceeding brought by the Clinical Trial Subject in connection with the Clinical Trial.
Medical Confidentiality. The Parties agree to adhere to the principles of medical confidentiality in relation to Clinical Trial Subjects involved in the Clinical Trial. Personal data (as defined in the Data Protection Act 1998) shall not be disclosed to the Sponsor by the Practice or the Investigator save where this is required to satisfy the requirements of the Protocol or for the purpose of monitoring or adverse event reporting, or in relation to a claim or proceeding brought by the Clinical Trial Subject in connection with the Clinical Trial. The Sponsor shall not disclose the identity of Clinical Trial Subjects to third parties without prior written consent of the Clinical Trial Subject, except in accordance with the provisions of the Data Protection Act 1998 and the principles set out in the NHS Confidentiality Code of Practice (November 2003), unless in relation to a claim or proceeding brought by the Clinical Trial Subject in connection with the Clinical Trial.
Medical Confidentiality. 6.6.1. The Parties agree to adhere to the local principles of medical confidentiality in relation to patients involved in the Project. Personal data (as defined in the Data protection Act 1998 or local laws) shall not be disclosed save where this is required directly or indirectly to satisfy the requirements of the Project or for the purpose of monitoring or Adverse Event reporting and subject always to compliance with the Data Protection Act 1998 and/or local laws on medical confidentiality.
6.6.2. The Collaborating Party shall not disclose the identity of patients to third parties without prior written consent of the patient except in accordance with the provisions of the Data Protection Act 1998 and/or local laws.
6.6.3. The obligations of this Clause 6.6 in respect of Medical Confidentiality shall remain in force without limit in time
Medical Confidentiality. 6.6.1. The Parties agree to adhere to the principles of medical confidentiality and data protection in relation to patients involved in the Research. Personal data (as defined in the Data Protection Legislation or Applicable laws) shall not be disclosed save where this is required directly or indirectly to satisfy the requirements of the Research or for the purpose of monitoring or adverse event reporting and subject always to compliance with the Data Protection legislation or Applicable Laws on medical confidentiality.
6.6.2. The Party shall not disclose the identity of patients/subjects to another Party or third parties without prior written consent of the patient/subject except in accordance with the provisions of the Data Protection Legislation and/or Applicable Laws.
6.6.3. The obligations of this Clause 6.6 in respect of Medical Confidentiality shall remain in force without limit in time
